Natural inhibitors for protein prenyltransferase
- PMID: 9619109
- DOI: 10.1055/s-2006-957439
Natural inhibitors for protein prenyltransferase
Abstract
Farnesyl protein transferase (FPT) catalyzes the posttranslational farnesylation of the cysteine residue located in the carboxyl-terminal tetrapeptide of the Ras oncoprotein. Prenylation of this residue is essential for membrane association and cell transforming activities of Ras. Inhibitors of FPT have been demonstrated to inhibit Ras-dependent cell transformation and thus represent a potential therapeutic strategy for the treatment of human cancers (1). In the present study, the inhibitory principles for protein prenyltransferases were isolated and identified from Ganoderma lucidum and garlic. The inhibitors from Ganoderma lucidum were identified as ganoderic acid A and ganoderic acid C by comparison with the reported spectral data. Ganoderic acid A has an IC50 value of 100 microM against FPT and its methyl ester (methyl ganoderate A) has an IC50 value of 38 microM for the same enzyme. These inhibitors appear to be competitive with farnesyl pyrophosphate (FPP), and Ki values of ganoderic acid A and methyl ganoderate A are 54 microM and 20 microM, respectively. The inhibitors from garlic were identified as diallyl thiosulfinate (allicin), methyl allyl thiosulfinate, and allyl methyl thiosulfinate. These inhibitors are more effective against geranylgeranyl protein transferase (GGPT) than FPT and IC50 values of allicin, methyl allyl thiosulfinate, and allyl methyl thiosulfinate for GGPT were 43 microM, 57 microM, and 53 microM, respectively. Methyl allyl thiosulfinate appears to be competitive with geranylgeranyl pyrophosphate (GGPP) and its Ki was determined to be 15 microM. The molecular structures of triterpenes and thiosulfinates are expected to be useful in designing lead compounds for new potent antitumour agents.
Similar articles
-
Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.J Med Chem. 1998 Nov 5;41(23):4492-501. doi: 10.1021/jm980356+. J Med Chem. 1998. PMID: 9804689
-
Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.Cancer Res. 2001 Dec 15;61(24):8758-68. Cancer Res. 2001. PMID: 11751396
-
In vitro virucidal effects of Allium sativum (garlic) extract and compounds.Planta Med. 1992 Oct;58(5):417-23. doi: 10.1055/s-2006-961504. Planta Med. 1992. PMID: 1470664
-
Farnesyl protein transferase inhibitors as potential cancer chemopreventives.Cancer Epidemiol Biomarkers Prev. 1997 Apr;6(4):267-82. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9107432 Review.
-
The development of protein farnesyltransferase inhibitors as signaling-based anticancer agents.Prog Cell Cycle Res. 2003;5:211-7. Prog Cell Cycle Res. 2003. PMID: 14593715 Review.
Cited by
-
Ganoderma lucidum (Reishi mushroom) for cancer treatment.Cochrane Database Syst Rev. 2016 Apr 5;4(4):CD007731. doi: 10.1002/14651858.CD007731.pub3. Cochrane Database Syst Rev. 2016. PMID: 27045603 Free PMC article.
-
Effect of Oral Coadministration of Ascorbic Acid with Ling Zhi Preparation on Pharmacokinetics of Ganoderic Acid A in Healthy Male Subjects: A Randomized Crossover Study.Biomed Res Int. 2016;2016:2819862. doi: 10.1155/2016/2819862. Epub 2016 Sep 25. Biomed Res Int. 2016. PMID: 27747224 Free PMC article. Clinical Trial.
-
Cancer Therapy Challenge: It Is Time to Look in the "St. Patrick's Well" of the Nature.Int J Mol Sci. 2021 Sep 26;22(19):10380. doi: 10.3390/ijms221910380. Int J Mol Sci. 2021. PMID: 34638721 Free PMC article. Review.
-
Identification of Biologically Active Ganoderma lucidum Compounds and Synthesis of Improved Derivatives That Confer Anti-cancer Activities in vitro.Front Pharmacol. 2019 Feb 19;10:115. doi: 10.3389/fphar.2019.00115. eCollection 2019. Front Pharmacol. 2019. PMID: 30837881 Free PMC article.
-
Enhancement of ATP generation capacity, antioxidant activity and immunomodulatory activities by Chinese Yang and Yin tonifying herbs.Chin Med. 2007 Mar 27;2:3. doi: 10.1186/1749-8546-2-3. Chin Med. 2007. PMID: 17386115 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources